COMMUNIQUÉS West-GlobeNewswire

Profound Medical to Release Third Quarter 2018 Financial Results on November 8 – Conference Call to Follow

30/10/2018 - 21:30

TORONTO, Oct. 30, 2018 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide a therapeutics platform that provides the precision of real-time [...]

CooperSurgical, Inc. Launches PGTai Technology Platform and ERPeak Endometrial Receptivity Test

30/10/2018 - 21:15

TRUMBULL, Conn., Oct. 30, 2018 (GLOBE NEWSWIRE) -- CooperSurgical, Inc. announced the launch of the CooperGenomics SM PGTai SM technology platform and ERPeak SM endometrial receptivity test at ASRM 2018. The PGTai SM [...]

CymaBay to Report Third Quarter 2018 Financial Results on Tuesday, November 6

30/10/2018 - 21:05

NEWARK, Calif., Oct. 30, 2018 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (Nasdaq: CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high [...]

Prothena to Report Third Quarter 2018 Financial Results on November 6

30/10/2018 - 21:05

DUBLIN, Ireland, Oct. 30, 2018 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a clinical-stage neuroscience company, will announce financial results for the third quarter and first nine months of 2018 on [...]

Cutera to Present at Three Upcoming Healthcare Conferences

30/10/2018 - 21:05

BRISBANE, Calif., Oct. 30, 2018 (GLOBE NEWSWIRE) -- CUTERA, INC., (Nasdaq: CUTR ) (“Cutera” or the “Company”) a leading provider of laser, light and other energy-based aesthetic systems for practitioners worldwide, [...]

BioTelemetry, Inc. Reports Third Quarter 2018 Financial Results

30/10/2018 - 21:05

Company’s Results Exceed Expectations Company Raises Full-Year Guidance MALVERN, Pa., Oct. 30, 2018 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote and wireless medical technology company [...]

KemPharm Enters Into License Agreement with KVK Tech for the Commercialization of APADAZ®

30/10/2018 - 21:05

Partnership with KVK, One of the Largest Manufacturers of Controlled Substances in the U.S., Opens the Door for Commercial Launch of APADAZ with PBMs and MCOs KemPharm to Host a Conference Call Today, Tuesday, October [...]

electroCore, Inc. to Report Third Quarter Financial Results on November 13, 2018

30/10/2018 - 21:05

BASKING RIDGE, N.J., Oct. 30, 2018 (GLOBE NEWSWIRE) -- electroCore, Inc. (“electroCore”) (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that it will release financial results for the [...]

Myriad Genetics to Present at the Stephens New York Investment Conference

30/10/2018 - 21:05

SALT LAKE CITY, Oct. 30, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and personalized medicine, announced today that R. Bryan Riggsbee, CFO, is scheduled to present [...]

CytomX Therapeutics to Announce Third Quarter 2018 Financial Results

30/10/2018 - 21:03

SOUTH SAN FRANCISCO, Calif., Oct. 30, 2018 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody [...]

Cara Therapeutics to Announce Third Quarter 2018 Financial Results on November 6, 2018

30/10/2018 - 21:01

STAMFORD, Conn., Oct. 30, 2018 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus and [...]

Xenon Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2018 Financial Results and Provide Corporate Update

30/10/2018 - 21:01

BURNABY, British Columbia, Oct. 30, 2018 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical-stage biopharmaceutical company, today announced that it will report its third quarter 2018 financial and [...]

Aduro Biotech Reports Third Quarter 2018 Financial Results

30/10/2018 - 21:01

BERKELEY, Calif., Oct. 30, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO) today reported financial results for the third quarter ended September 30, 2018. Net loss for the third quarter of 2018 was $23.1 [...]

Cerecor Receives Rare Pediatric Disease Designation for CERC-801 for Patients with Inborn Error of Metabolism

30/10/2018 - 21:00

BALTIMORE, Oct. 30, 2018 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments for rare and orphan diseases in [...]

Changes in Clocks and Amount of Light Affect Sleep and Health - Tips from a Sleep Physician to Successfully Deal with Fall’s Time Change and Reduced Daylight Hours

30/10/2018 - 20:12

CALGARY, Alberta, Oct. 30, 2018 (GLOBE NEWSWIRE) -- The clocks go back an hour at 02:00 AM Sunday morning, providing an extra hour of much needed sleep. “As many as 30 per cent of people in society are chronically sleep [...]

OSE Immunotherapeutics Presents Selective SIRP-alpha antibodies: OSE-172, a next-generation myeloid checkpoint inhibitor at the World Immunotherapy Congress

30/10/2018 - 18:00

Basel, Oct. 29-31, 2018 NANTES, France, Oct. 30, 2018 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnémo: OSE) presented at the World Immunotherapy Congress held on Oct. 29-31, 2018 in Basel, [...]

NEOVACS : HALF-YEAR 2018 FINANCIAL RESULTS

30/10/2018 - 17:51

PRESS RELEASE · PRESS RELEASE · PRESS RELEASE HALF-YEAR 2018 FINANCIAL RESULTS STRENGTHENED CASH POSITION: € 4.7 M AT JUNE 30 2018 VS € 1.7 M AT JUNE 30 2017 LOWER OPERATING COSTS, CONSISTENT WITH THE END OF THE [...]

NEOVACS : RÉSULTATS SEMESTRIELS 2018

30/10/2018 - 17:51

COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE RÉSULTATS SEMESTRIELS 2018 RENFORCEMENT DE LA POSITION DE TRÉSORERIE : 4,7M € AU 30 JUIN 2018 VS 1,8 M€ AU 30 JUIN 2017 RÉDUCTION DES CHARGES D' [...]

Composition of the Nomination Committee of Orion Corporation

30/10/2018 - 17:31

ORION CORPORATION STOCK EXCHANGE RELEASE 30 OCTOBER 2018 at 6.30 P.M. EET Composition of the Nomination Committee of Orion Corporation The Board of Directors of Orion Corporation has elected the following persons to the [...]